Bone growth stimulator market

Q: Which is the leading end user segment in the market?

Hospitals is the leading end user segment in the market. Read more

Bone Growth Stimulator Market, by Product Type (Non-invasive Electrical Bone Growth Stimulators(Capacitive coupling (CC) devices, Pulsed electromagnetic field (PEMF) devices, Combined magnetic field (CMF) devices)), Invasive Electrical Bone Growth Stimulators, Ultrasound Bone Growth Stimulators, by Application (Trauma injury and Fractures, Spinal Fusion, Ontogenesis), by End User (Hospitals, Ambulatory Surgical Centers, Orthopaedic Clinics, Home Care), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

Request Free Sample

Aug 2022
CMI225
220 Pages
Excel & Pdf
Medical Devices

Summary

Bone growth stimulation is utilized to promote bone healing in fractures which are difficult to heal. Bone growth stimulators are used to enhance the bone healing process without the sensation of electrical shocks, currents or vibrations when being worn by the user. The devices stimulate the natural healing process of bone by sending low level pulses of electromagnetic energy to the injury or fusion site.

Global bone growth stimulator market is estimated to be valued at US$ 1,678.0 million in 2022 and is expected to exhibit a CAGR of 5.6% during the forecast period (2022-2030).

Figure 1. Global Bone Growth Stimulator Market Share (%), by End User, 2022

Increasing prevalence of osteoporosis and osteoarthritis is expected to boost growth of the global bone growth stimulator market over the forecast period.

Increasing prevalence of osteoporosis and osteoarthritis is expected to boost growth of the global bone growth stimulators market over the forecast period. For instance, according to the study ‘Epidemiology and awareness of osteoporosis: a viewpoint from the Middle East and North Africa’ published in the International Journal of Clinical Rheumatology, in 2018, the prevalence of osteoporosis was 15.1% among women and 10.7% among men in Turkey. Moreover, high incidence of osteoporosis and osteopenia was detected among patients admitted to the geriatric department.

Moreover, in January 2021, according to data published by the National Center for Biotechnology Information, in the U.K. over 3 million people are estimated to have osteoporosis and there are estimated to be over 500,000 fragility fractures that occur in the U.K. each year. The highest prevalence of osteoporosis in the studied in Iran with 77.3% in 2019.

Bone Growth Stimulator Market Report Coverage

Report Coverage	Details
Base Year:	2021	Market Size in 2022:	US$ 1,678.0 Mn
Historical Data for:	2017 to 2020	Forecast Period:	2022 to 2030
Forecast Period 2022 to 2030 CAGR:	5.6%	2030 Value Projection:	US$ 2,599.7 Mn
Geographies covered:	North America: U.S. and Canada Latin America: Brazil, Argentina, Mexico, and Rest of Latin America Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific Middle East: GCC Countries, Israel, and Rest of Middle East Africa: South Africa, North Africa, and Central Africa
Segments covered:	By Product Type: Non-invasive Electrical Bone Growth Stimulators (Capacitive coupling (CC) devices, Pulsed electromagnetic field (PEMF) devices, Combined magnetic field (CMF) devices), Invasive Electrical Bone Growth Stimulators, Ultrasound Bone Growth Stimulators By Application: Trauma injury and Fractures, Spinal Fusion, Ontogenesis By End User: Hospitals, Ambulatory Surgical Centers, Orthopedic Clinics, Home Care
Companies covered:	DJO LLC, Orthofix International N.V., Zimmer Biomet Holdings Inc., Elizur, Bioventus LLC., Precyse Solutions LLC., Ossatec Benelux BV, Verve Consulting Inc., and IGEA S.p.A.
Growth Drivers:	Increasing prevalence of osteoporosis and osteoarthritis Increasing geriatric population
Restraints & Challenges:	Availability of alternatives to bone growth stimulators

Figure 2. Global Bone Growth Stimulator Market Share (%), by Region, 2022

Increasing geriatric population is also expected to contribute to growth of market during the forecast period.

Increasing geriatric population is also expected to contribute to growth of market during the forecast period. For instance, according to the National Center for Biotechnology Information by 2050, the population of Egypt is expected to reach 130 million, of which over 30% would be aged 50 years and over. According to the Center for Disease Control and Prevention, in May 2022, the share of the global population aged 65 years or above is projected to rise from 10 per cent in 2022 to 16 per cent in 2050. Since 1900, the percentage of Americans aged 65 and older nearly quadrupled (from 4.1% in 1900 to 16% in 2019), and the number increased more than 17 times in 2022 (from 3.1 million to 54.1 million). The older population itself became increasingly older.

Furthermore, in October 2021, according to data published by the World Health Organization, by 2020, the number of people aged 60 years and older would outnumber children younger than 5 years. In 2050, 80% of older people would be living in low- and middle-income countries. By 2030, 1 in 6 people in the world would be aged 60 years or over. At this time the share of the population aged 60 years and over would increase from 1 billion in 2020 to 1.4 billion. By 2050, the world’s population of people aged 60 years and older would double (2.1 billion). The number of persons aged 80 years or older is expected to triple between 2020 and 2050 to reach 426 million.

Global Bone Growth Stimulator Market– Impact of Coronavirus (COVID-19) Pandemic

Since the COVID-19 virus outbreak in December 2019, the disease has spread to over 100 countries across the globe and the World Health Organization had declared it a public health emergency on January 30, 2020.

COVID-19 can affect the economy in three main ways: by directly affecting production and demand of drugs, medical devices, etc. by creating disruptions in distribution channels, and through its financial impact on firms and financial markets. Due to nationwide lockdowns, several countries, such as China, India, Saudi Arabia, U.A.E., Egypt, and others, are facing problems with regards to the transportation of drugs and medical devices from one place to another.

However, the COVID-19 pandemic had a negative impact on the global bone growth stimulator market, owing to decrease in research and development activities for bone growth stimulators by key players in market. For instance, in July 2020, according to the data published by the National Center for Biotechnology Information, the COVID-19 pandemic and associated disruptions have had a major impact on the U.S. academic research enterprise. Several traditional research activities were largely suspended in the month of February to May other than COVID-19-related and other essential research. Key players in market were focusing on the development of vaccines for prevention of spread of coronavirus. Moreover, the lockdown imposed by the governments of the countries made it difficult for the key players to carry out the research and development activities smoothly on commercial basis.

Global Bone Growth Stimulator Market: Key Developments

In May 2022, Orthofix Medical Inc., a medical device company with a spine and orthopedics focus announced the U.S. Food and Drug Administration (FDA) pre-market approval for the AccelStim bone healing therapy Class III device. The device generates a Low-Intensity Pulsed Ultrasound (LIPUS) signal to stimulate the bone’s natural healing process to promote fracture healing. Commercial availability of the AccelStim device is anticipated to occur in the second quarter of 2022 year through a targeted and phased launch plan.

Global Bone Growth Stimulator Market: Restraint

The major factors that hinder growth of the global bone growth stimulator market include availability of alternatives to bone growth stimulators. Traditional physiotherapy, yoga or Ayurveda treatment options are often recommended for non-union or delayed union bone fractures. Moreover, chiropractic is also used in diagnosis and treatment of mechanical disorders of the musculoskeletal system.

Key Players

Major players operating in the global bone growth stimulator market include DJO LLC, Orthofix International N.V., Zimmer Biomet Holdings Inc., Elizur, Bioventus LLC., Precyse Solutions LLC., Ossatec Benelux BV, Verve Consulting Inc., and IGEA S.p.A.

Table of Content

Table of Contents

*Browse 42 market data tables and 44 figures on “Global Bone Growth Stimulator Market” - forecast to 2030

Segmentation

Detailed Segmentation:

- Frequently Asked Questions -

What is the current market size and compound annual growth rate (CAGR) of the global bone growth stimulator market during the forecast period (2022-2030)?

The global bone growth stimulator market size is estimated to be valued at US$ 1,678.0 million in 2022 and is expected to exhibit a CAGR of 5.6% between 2022 and 2030.

What are the major factors driving the market growth?

Factors such as increasing prevalence of osteoporosis and osteoarthritis and increasing geriatric population are expected to drive the market growth.

Which is the leading end user segment in the market?

Hospitals is the leading end user segment in the market.

What are the key factors hampering growth of the market?

The major factors hampering growth of the market include availability of alternatives to bone growth stimulators.

Which are the major players operating in the market?

Major players operating in the market include DJO LLC, Orthofix International N.V., Zimmer Biomet Holdings Inc., Elizur, Bioventus LLC., Precyse Solutions LLC., Ossatec Benelux BV, Verve Consulting Inc., and IGEA S.p.A.